Search engine for other government resources

Atomoxetine MedlinePlus Drug Information

Atomoxetine comes as a capsule to take by mouth. It is usually taken either once a day in the morning, or twice a day in the morning and late ...
medlineplus.gov/druginfo/meds/a603013.html

Atomoxetine C17H21NO - PubChem

Atomoxetine is a selective norepinephrine reuptake inhibitor used primarily for therapy of attention deficit hyperactivity disorder. Atomoxetine has ...
pubchem.ncbi.nlm.nih.gov/compound/Atomoxetine

Atomoxetine a review of its use in attention-deficit ...

Atomoxetine (Strattera(R)) is a selective norepinephrine (noradrenaline) reuptake inhibitor that is not classified as a stimulant, and is indicated ...
pubmed.ncbi.nlm.nih.gov/19445548/

PDF STRATTERA

STRATTERA (atomoxetine HCl) is a selective norepinephrine reuptake inhibitor. Atomoxetine HCl is the R(-) isomer as determined by x-ray diffraction ...
www.accessdata.fda.gov/drugsatfda_docs/label/2007/021411s004s012s013s015s021lbl.pdf

Efficacy and safety of atomoxetine for attention-deficit ...

Atomoxetine is efficacious in reducing ADHD symptoms. It may have a role in treating comorbid ODD or depression, and probably in comorbid anxiety.
pubmed.ncbi.nlm.nih.gov/17572882/

Atomoxetine hydrochloride C17H22ClNO - PubChem

Atomoxetine Hydrochloride is the hydrochloride salt of atomoxetine, a phenoxy-3-propylamine derivative and selective non-stimulant, norepinephrine ...
pubchem.ncbi.nlm.nih.gov/compound/Atomoxetine-hydrochloride

Atomoxetine a novel treatment for child and adult ADHD

Atomoxetine was originally named tomoxetine, with initial research completed for an indication of the treatment of major depression (Zerbe et al ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC2671957/

Atomoxetine Therapy and CYP2D6 Genotype - Medical Genetics ...

Atomoxetine (brand name Strattera) is a non-stimulant drug used in the treatment of attention-deficit hyperactivity disorder (ADHD). It is a selective ...
www.ncbi.nlm.nih.gov/books/NBK315951/?report=reader

Atomoxetine Used Adjunctively With Selective Serotonin ...

Atomoxetine is approved for the treatment of attention-deficit/ hyperactivity disorder, 4 and its use in depression is outside the scope of this U.S ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC427606/

Isolated atomoxetine overdose resulting in seizure

Atomoxetine acts by inhibiting the reuptake of norepinephrine. There are limited reports of the effects of atomoxetine in overdose. We report a case ...
pubmed.ncbi.nlm.nih.gov/17307628/

Atomoxetina MedlinePlus medicinas

Los estudios han demostrado que los nios y adolescentes con trastorno de dficit de atencin e hiperactividad (TDAH; tienen ms dificultad para ...
medlineplus.gov/spanish/druginfo/meds/a603013-es.html

Amphetamines atomoxetine and the risk of serious ...

Main objective: To compare the incidence rates of serious cardiovascular events in adult initiators of amphetamines or atomoxetine to rates in ...
pubmed.ncbi.nlm.nih.gov/23382829/

Adjunctive atomoxetine to SSRIs or SNRIs in the treatment ...

All patients were treated with atomoxetine as adjunctive to SSRIs or to SNRIs and were followed for at least 12 weeks. The primary outcome measure was ...
pubmed.ncbi.nlm.nih.gov/21833565/

Cardiovascular effects of atomoxetine in children ...

While atomoxetine has noradrenergic activity, increases in pulse and blood pressure were small and of little, if any, clinical significance. Atomoxeti ...
pubmed.ncbi.nlm.nih.gov/12862507/

Profile of sexual and genitourinary treatment-emergent ...

Background: Attention-deficit hyperactivity disorder (ADHD) is a neuropsychiatric disorder that begins in childhood. Atomoxetine is a selective ...
pubmed.ncbi.nlm.nih.gov/23775507/

DailyMed - ATOMOXETINE- atomoxetine hydrochloride capsule

Atomoxetine HCl is a white to practically white solid, which has a solubility of 27.8 mg/mL in water. Atomoxetine capsules are intended for oral ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48980c85-2fa0-4c9e-b182-227b0d057f6b

Changes in symptoms and adverse events after ...

Atomoxetine, a new dru Drugs that affect neurotransmitter release can induce changes in neuroregulation during chronic administration. Thus, in ...
pubmed.ncbi.nlm.nih.gov/14709944/

Effects of atomoxetine on heart rhythm in children and ...

Atomoxetine did not cause significant changes in ECG or Holter variables. In two patients, who had undiagnosed subclinical extrasystoles, extra beats ...
pubmed.ncbi.nlm.nih.gov/26096186/

Anxiety reduction on atomoxetine and methylphenidate ...

Background: Atomoxetine and methylphenidate are widely used to treat attention-deficit-hyperactivity disorder (ADHD) with similar effectiveness after ...
pubmed.ncbi.nlm.nih.gov/26579704/

A Systematic Review of Combination Therapy with Stimulants ...

Both atomoxetine (Wernicke et al. 2003) and stimulants (Wilens et al. 2004) have known long-term cardiovascular effects. In general, the included ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC3696926/